April 16, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX“), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, announces participation in the 12th annual Scottsdale Capital Event sponsored by Capital Events Management (“CEM”) to be held in Scottsdale, Arizona on April 19-21, 2024.
This event will give top-tier investors the opportunity to meet FendX’s CEO, Dr. Carolyn Myers for one-on-one meetings and provide for networking opportunities throughout the event.
“We are excited to be attending another conference hosted by CEM where we will have the opportunity to meet with investors and share with them the progress we are making with our nano-coating projects, including optimizing the pilot manufacturing process for our REPELWRAP™ film, as well as next steps to prepare us for commercial production of our film,” said Dr. Carolyn Myers, CEO and President of FendX. “We are pleased with the accomplishments we achieved in 2023 and during the first quarter of 2024 and we remain committed to advancing our nanotechnology projects throughout the remainder of 2024.”
The Company also announces that it has entered into an investor relations services agreement with Black Swan Solutions Inc. (dba VHLA Media) (“Black Swan”) on April 15, 2024. Pursuant to the agreement, Black Swan has agreed to provide investor communication and digital marketing services to the Company for a period of one month commencing on or about May 13, 2024 until June 12, 2024 in exchange for a fee of CDN $25,000 plus GST. The term may be renewed for subsequent periods of one or more months at the discretion of the Company. The services include content creation, digital and social media marketing. Black Swan and its principals are arm’s length to the Company. Black Swan contact information is as follows: 14301-312 256th, Maple Ridge, BC, attention: Dawson Ignatieff, [email protected], telephone: 604-762-1611.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
ON BEHALF OF THE BOARD
“Carolyn Myers”
Carolyn Myers
Chief Executive Officer and Director
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
Alyssa Barry, Investor Relations
1-833-947-5227
[email protected]
For more information, please visit https://fendxtech.com/ and the Company’s profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; next steps to prepare for commercialization of the Company’s film; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company’s public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company’s such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors should change.
Leave a Reply